Knock-Out Finder
Your selection:
20 Results
| MG34RC |  | Sarepta Therapeutics Inc./Faktor/Short [2]/MS | - | - | put | Sarepta Therapeutics Inc. | 25.244 | 25.244 | - | 55.733% | - | Morgan Stanley | |
| MK4C09 | | Sarepta Therapeutics Inc./Faktor/Long [2]/MS | - | - | call | Sarepta Therapeutics Inc. | 8.417 | 8.417 | - | 48.076% | - | Morgan Stanley | |
| MK9P2N | | Sarepta Therapeutics Inc./Faktor/Long [2]/MS | - | - | call | Sarepta Therapeutics Inc. | 8.417 | 8.417 | - | 48.076% | - | Morgan Stanley | |
| MM1ZMM | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 12.988 | 12.988 | - | 19.877% | - | Morgan Stanley | |
| MM6X8H | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 6.787 | 8.490 | 1.701 | 47.625% | - | Morgan Stanley | |
| MM6X8J | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 10.180 | 12.730 | 2.637 | 21.468% | - | Morgan Stanley | |
| MN068X | | Sarepta Therapeutics Inc./Faktor/Long [3]/MS | - | - | call | Sarepta Therapeutics Inc. | 11.223 | 11.223 | - | 30.768% | - | Morgan Stanley | |
| MN10NY | | Sarepta Therapeutics Inc./Faktor/Long [4]/MS | - | - | call | Sarepta Therapeutics Inc. | 12.625 | 12.625 | - | 22.114% | - | Morgan Stanley | |
| MN10NZ | | Sarepta Therapeutics Inc./Faktor/Long [5]/MS | - | - | call | Sarepta Therapeutics Inc. | 13.467 | 13.467 | - | 16.922% | - | Morgan Stanley | |
| MN123Y | | Sarepta Therapeutics Inc./Faktor/Short [4]/MS | - | - | put | Sarepta Therapeutics Inc. | 21.037 | 21.037 | - | 29.778% | - | Morgan Stanley | |
| MN123Z | | Sarepta Therapeutics Inc./Faktor/Short [5]/MS | - | - | put | Sarepta Therapeutics Inc. | 20.196 | 20.196 | - | 24.587% | - | Morgan Stanley | |
| MN624J | | Sarepta Therapeutics Inc./Faktor/Long [5]/MS | - | - | call | Sarepta Therapeutics Inc. | 13.467 | 13.467 | - | 16.922% | - | Morgan Stanley | |
| MN88T9 | | Sarepta Therapeutics Inc./Faktor/Short [3]/MS | - | - | put | Sarepta Therapeutics Inc. | 22.439 | 22.439 | - | 38.429% | - | Morgan Stanley | |
| MN9LJ1 | | Sarepta Therapeutics Inc./Faktor/Long [4]/MS | - | - | call | Sarepta Therapeutics Inc. | 12.625 | 12.625 | - | 22.114% | - | Morgan Stanley | |
| MN9XXV | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 12.169 | 12.169 | 3.542 | 24.931% | - | Morgan Stanley | |
| MN9XXW | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 14.197 | 14.197 | - | 12.419% | - | Morgan Stanley | |
| MR153C | | Sarepta Therapeutics Inc./Faktor/Long [3]/MS | - | - | call | Sarepta Therapeutics Inc. | 11.223 | 11.223 | - | 30.768% | - | Morgan Stanley | |
| MR1GG9 | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 11.304 | 14.140 | 3.220 | 12.770% | - | Morgan Stanley | |
| MR2E5P | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 15.092 | 15.092 | - | 6.899% | - | Morgan Stanley | |
| MR3G58 | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 12.837 | 16.050 | - | 0.987% | - | Morgan Stanley |